A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

Bendamustine_90_Rituximab

Description
Chemotherapy Protocol CHRONIC LYMPHOCYTIC LEUKAEMIA BENDAMUSTINE (90)-RITUXIMAB There are multiple versions of this protocol in use that vary depending on the indication. Please ensure you have the correct protocol for the rel
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Bendamustine-90-Rituximab.pdf

Bendamustine_70_RituximabSplit

Description
Chemotherapy Protocol CHRONIC LYMPHOCYTIC LEUKAEMIA BENDAMUSTINE (70)-RITUXIMAB (Split) This protocol may require funding There are multiple versions of this protocol in use that vary depending on the indication. Please ensure
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Bendamustine-70-RituximabSplit.pdf

Bendamustine_70_Rituximab

Description
Chemotherapy Protocol CHRONIC LYMPHOCYTIC LEUKAEMIA BENDAMUSTINE (70)-RITUXIMAB There are multiple versions of this protocol in use that vary depending on the indication. Please ensure you have the correct protocol for the rel
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Bendamustine-70-Rituximab.pdf

Interstitial lung disease (ILD) clinical nurse specialist team - patient information

Description
This factsheet explains who the interstitial lung disease (ILD) clinical nurse specialist team are and how we can support you throughout
Url
/Media/UHS-website-2019/Patientinformation/Respiratory/Interstitial-lung-disease-ILD-clinical-nurse-specialist-team-3644-PIL.pdf

Papers Trust Board - 29 November 2022

Description
Date Time Location Chair Agenda Trust Board – Open Session 29/11/2022 9:00 - 13:20 Conference Room, Heartbeat/Microsoft Teams
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/Papers-Trust-Board-29-November-2022.pdf

mini-RCHOP 21

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-DOXORUBICIN-PREDNISOLONE-RITUXIMAB-VINCRISTINE (mini-RCHOP 21) Regimen   Lymphoma – mini-RCHOP (21)-Cyclophosphamide-Doxorubicin-PrednisoloneRituximab-Vincr
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/mini-RCHOP-21.pdf

UHS Our People Strategy 2022 - 2026

Description
OUR PEOPLE STRATEGY 2022 to 2026 CONTENTS 05 Foreword by Steve Harris – chief people officer 06 Our strategic framework 07 Always Improving 08 Insights f
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Plans-and-strategies/UHS-Our-People-Strategy-2022-2026.pdf

RPMitCEBO-Bleomycin-Cyclophosphamide-Etoposide-Mitoxantrone-Prednisolone-Rituximab-Vincristine Ver 1.4

Description
Chemotherapy Protocol LYMPHOMA BLEOMYCIN-CYCLOPHOSPHAMIDE-ETOPOSIDE-MITOXANTRONE-PREDNISOLONERITUXIMAB-VINCRISTINE (RPMitCEBO) Regimen  Lymphoma – RPMitCEBO-Bleomycin-Cyclophosphamide-Etoposide-Mitoxa
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/RPMitCEBO-Bleomycin-Cyclophosphamide-Etoposide-Mitoxantrone-Prednisolone-Rituximab-Vincristine-Ver-1.4.pdf

RPACEBOM - Bleomycin-Cyclophosphamide-Doxorubicin-Etoposide-Methotrexate-Prednisolone-Rituximab-Vincristine

Description
Chemotherapy Protocol LYMPHOMA BLEOMYCIN-CYCLOPHOSPHAMIDE-DOXORUBICIN-ETOPOSIDE-METHOTREXATEPREDNISOLONE-RITUXIMAB-VINCRISTINE Regimen (RPACEBOM) Lymphoma – RPACEBOM-Bleomycin-Cyclophosphamide-Doxorubi
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/RPACEBOM-Bleomycin-Cyclophosphamide-Doxorubicin-Etoposide-Methotrexate-Prednisolone-Rituximab-Vincristine.pdf

RGCVP-Cyclophosphamide-Gemcitabine-Prednisolone-Rituximab-Vincristine Ver 1.2

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-GEMCITABINE-PREDNISOLONE-RITUXIMAB-VINCRISTINE (RGCVP) Regimen Lymphoma–RGCVP-Cyclophosphamide-Gemcitabine-Prednisolone-RituximabVincristine Indication C
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/RGCVP-Cyclophosphamide-Gemcitabine-Prednisolone-Rituximab-Vincristine-Ver-1.2.pdf
61 to 70 of 127
Previous … 5 6 7 8 9 … Next